The global chytridiomycosis pandemic caused by the pathogen Batrachochytrium dendrobatidis (Bd) is implicated in the apparent extinction or severe decline of over 200 amphibian species. Many declined species now only persist in isolated remnant populations. In this study we examine how remnant populations coexist with Bd, focusing on disease impact on adult survival and recruitment potential in the chytridiomycosis-threatened frog Litoria verreauxii alpina. Using skeletochronology we found that the adult male population in both 2011 and 2012 was dominated by a two year old age cohort. The lack of recruitment into the three year old cohort in 2012 indicates that annual adult survival is very low. Combined with high Bd prevalence and heavy infection burdens, the pathogen appears to drive almost complete mortality of breeding adults over their first breeding season. However, adults successfully mate prior to large increases in disease prevalence that occurs during the breeding season. Infection prevalence among tadpoles and juveniles is low. Exposure to warm water could provide a mechanism for avoiding or clearing Bd infection. Relatively low Bd prevalence in juveniles prior to dispersal into terrestrial habitat indicates that Bd has minimal impact on early life history stages. As such, recruitment is probably high, allowing populations to persist despite low adult survival. This dependence on reliable annual recruitment may explain why remnant populations persist in permanent ponds rather than ephemeral ponds that were historically occupied. New management strategies that focus on increasing recruitment may provide a way forward for the management of disease-threatened amphibian species.
Potentiating the evolution of immunity is a promising strategy for addressing biodiversity diseases. Assisted selection for infection resistance may enable the recovery
The impacts of pathogen emergence in naïve hosts can be catastrophic, and pathogen spread now ranks as a major threat to biodiversity. However, pathogen impacts can persist for decades after epidemics and produce variable host outcomes. Chytridiomycosis in amphibians (caused by the fungal pathogen Batrachochytrium dendrobatidis, Bd) is an exemplar, with impacts ranging from rapid population crashes and extinctions, to population declines and subsequent recoveries. Here, we investigate long-term impacts associated with chytridiomycosis in Australia. We conducted a continent-wide assessment of the disease, reviewing data collected since the arrival of Bd in about 1978, to assess and characterize mechanisms driving past, present and future impacts. We found chytridiomycosis to be implicated in the extinction or decline of 43 of Australia's 238 amphibian species. Population trajectories of declined species are highly variable; six species are experiencing ongoing declines, eight species are apparently stable and 11 species are recovering. Our results highlight that while some species are expanding, Bd continues to threaten species long after its emergence. Australian case-studies and synthesis of the global chytridiomycosis literature suggests that amphibian reservoir hosts are associated with continued declines in endemically infected populations, while population stability is promoted by environmental conditions that restrict Bd impact, and maintenance of high recruitment capacity that can offset mortality. Host genetic adaptation or decreased pathogen virulence may facilitate species recovery, but neither has been empirically demonstrated. Understanding processes that influence Bd-host dynamics and population persistence is crucial for assessing species extinction risk and identifying strategies to conserve disease-threatened species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.